Processing timeline
23
days
Acquirer(s)
Project Saint Merger Sub, Inc. 10489040, United States Surgical Corporation 13-2518270, Medtronic plc 98-1183488
Target(s) or Vendor(s)
Scientia Vascular, Inc. 5931868
Other parties
None listed
Global healthcare technology company Medtronic plc, via its subsidiary Project Saint Merger Sub, Inc., is acquiring medical device company Scientia Vascular, Inc. Both parties operate in the medical and surgical equipment manufacturing industry, specifically supplying neurovascular guidewires in Australia. This is a share acquisition.
Medtronic plc (Medtronic), via its indirect wholly-owned subsidiary Project Saint Merger Sub, Inc., proposes to acquire Scientia Vascular, Inc. (Scientia) (the Acquisition). Medtronic is a global healthcare technology company incorporated in Ireland and listed on the New York Stock Exchange. Globally (including in Australia), Medtronic develops, manufactures, distributes and sells device-based medical therapies and services within its cardiovascular, neuroscience and medical surgery portfolios. In Australia, Medtronic operates through its Australian subsidiary, Medtronic Australasia Pty Ltd, to supply medical devices, including neurovascular devices such as guidewires, catheters, aspiration catheters, embolic coils, flow diverters, liquid embolic agents, intrasaccular devices, AB stents and stent retrievers. In relation to the supply of guidewires in Australia, Medtronic supplies its Mirage .008” guidewire. Scientia is a medical device company headquartered in West Valley City, Utah, USA. Scientia specialises in microfabrication technology for guidewires and catheters used in neurovascular and peripheral vascular procedures. In Australia, Scientia supplies guidewires under its “Aristotle” brand through a third-party distributor, LifeHealthcare Pty Ltd. The Aristotle-branded guidewires are supplied in Australia in four diameter configurations, .014”, .018”, .024”, and .035”. Both Medtronic and Scientia supply neurovascular guidewires in Australia.